Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

604
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
604
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

511
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
511
Genetic Screens02:46

Genetic Screens

5.4K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

531
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In active UC, upadacitinib induced and maintained remission.

Annals of internal medicine·2022
Same author

Opportunistic detection of anal intraepithelial neoplasia at colonoscopy.

JGH open : an open access journal of gastroenterology and hepatology·2020
Same author

Celiac Disease Patients Should No Longer Be Consuming Measurable Amounts of Gluten.

Gastroenterology·2020
Same author

Improving the Treatment of Celiac Disease.

The American journal of gastroenterology·2019
Same author

Gluten in "gluten-free" manufactured foods in Australia: a cross-sectional study.

The Medical journal of Australia·2019
Same author

Mesenchymal Stromal Cell Therapy in Crohn's Disease.

Digestive diseases (Basel, Switzerland)·2017

Related Experiment Video

Updated: Dec 5, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K

"ASKing" the Right Questions About Screening for Celiac Disease.

Geoffrey M Forbes1

  • 1School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia.

The American Journal of Gastroenterology
|October 20, 2020
PubMed
Summary

Distinguishing between symptom investigation and disease screening is crucial. A Colorado study highlights challenges in applying these principles to population-based Celiac disease screening, emphasizing patient benefit and informed follow-up.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.9K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.8K

Related Experiment Videos

Last Updated: Dec 5, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.9K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.8K

Area of Science:

  • Medical diagnostics and public health screening strategies.

Background:

  • Differentiating between diagnostic testing for symptomatic individuals and screening asymptomatic populations is essential for appropriate healthcare.
  • Understanding test performance characteristics in both symptomatic and asymptomatic (average or elevated risk) individuals is critical for accurate interpretation.
  • Positive screening results necessitate comprehensive patient education and timely follow-up care.

Purpose of the Study:

  • To clarify the distinctions between investigating symptoms and screening for disease.
  • To emphasize the importance of understanding test performance in different risk groups.
  • To evaluate the practical application of screening principles in population-based Celiac disease screening.

Main Methods:

  • Review of diagnostic and screening principles.
  • Analysis of test performance characteristics in symptomatic versus asymptomatic individuals.
  • Examination of a large-scale population-based Celiac disease screening study in Colorado.

Main Results:

  • Screening should offer a clear advantage to the individual, with treatment being in their best interest.
  • The practical implementation of population-based Celiac disease screening presents significant challenges.
  • Performance characteristics of tests differ substantially between symptomatic investigation and asymptomatic screening.

Conclusions:

  • Careful consideration of patient benefit and treatment efficacy is paramount in screening programs.
  • Population-based screening requires careful evaluation to ensure it is advantageous for the individual.
  • The Colorado study indicates difficulties in applying established screening principles to Celiac disease on a large scale.